SCHEMBL15564302

SCHEMBL15564302

CCCCCCCCCCC(C(N)=O)(c1ccccc1)c1ncco1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 3/20 0.44
SCN9A Q15858 3/20 0.44
KDM4E B2RXH2 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
KCNH2 Q12809 2/20 0.41
OPRK1 P41145 2/20 0.41
CYP3A4 P08684 2/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41
PGR P06401 1/20 0.41
THRB P10828 1/20 0.41
ADRB3 P13945 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
PDE3A Q14432 1/20 0.41
SLC47A1 Q96FL8 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CHRM3 P20309 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15564219 1.00 SCN5A (0.44) SCN5ASCN9AKDM4ECTDSP1KCNH2
SCHEMBL18248486 0.83 CHRM3 (0.54) SCN5ASCN9AKDM4ECTDSP1KCNH2
SCHEMBL18248596 0.83 CHRM3 (0.54) SCN5ASCN9AKDM4ECTDSP1KCNH2
SCHEMBL7643094 0.83 CHRM3 (0.54) SCN5ASCN9AKDM4ECTDSP1KCNH2
SCHEMBL15564307 0.81 SCN5A (0.40) SCN5ASCN9AOPRK1CYP3A4LMNA
SCHEMBL15564311 0.80 FAAH (0.40) SCN5ASCN9AOPRK1CYP3A4TDP1
SCHEMBL9030777 0.79 PPARG (0.42) KDM4EKCNH2OPRK1CYP3A4SLC22A2
Phosphoric Acid SCHEMBL3688742 0.78 CHRM2 (0.49) SCN5ASCN9AKDM4ECTDSP1KCNH2
Phosphoric Acid SCHEMBL29728497 0.78 CHRM2 (0.49) SCN5ASCN9AKDM4ECTDSP1KCNH2
SCHEMBL2073778 0.77 CYP3A4 (0.43) SCN5ASCN9AKDM4ECTDSP1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882724-A1 COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC IRBM - Science Park S.p.A. (IT) 2015-06-17 EP disclosed
WO-2014023754-A1 COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC IRBM - SCIENCE PARK S.P.A. (IT) 2014-02-13 WO disclosed